Gofen & Glossberg LLC Viatris Inc Transaction History

Gofen & Glossberg LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$9.81 - $15.4 $102,465 - $160,853	-10,445 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$12.09 - $14.68 $16,019 - $19,451	-1,325 Reduced 11.26%	10,445 $141,000
Q3 2021 Oct 13, 2021	SELL	$13.25 - $15.13 $7,049 - $8,049	-532 Reduced 4.32%	11,770 $159,000
Q2 2021 Jul 13, 2021	SELL	$12.97 - $16.15 $23,955 - $29,829	-1,847 Reduced 13.05%	12,302 $176,000
Q1 2021 Apr 13, 2021	SELL	$13.59 - $18.54 $131,823 - $179,838	-9,700 Reduced 40.67%	14,149 $198,000
Q4 2020 Jan 15, 2021	BUY	$14.3 - $18.74 $341,040 - $446,930	23,849 New	23,849 $447,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

Stay updated on Gofen & Glossberg LLC with notifications on news.